Bangkok

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Astellas Pharma Global Development, Inc.2 trials

Running trials

• Active, not recruiting

  A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

  NCT03653507· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Active, not recruiting

  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

  NCT02960022· Phase 2· Astellas Pharma Global Development, Inc.· Source